Description
Mounjaro (tirzepatide) is a once‑weekly injectable for type 2 diabetes that improves blood sugar and supports weight loss. Learn dosing, benefits, safety, side effects, and patient tips.What is Mounjaro
Mounjaro contains tirzepatide, a once‑weekly injectable that acts on both GIP and GLP‑1 receptors to improve glycaemic control in adults with type 2 diabetes. The product carries a boxed warning about thyroid C‑cell tumors observed in animal studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.
How does Mounjaro work for weight loss?
Tirzepatide is a dual GIP/GLP‑1 receptor agonist that enhances glucose‑dependent insulin secretion, reduces inappropriate glucagon release, slows gastric emptying, and reduces appetite—mechanisms that together lower fasting and postprandial glucose and often produce substantial weight loss in clinical trials.
Mounjaro mimics the effects of GLP-1 and GIP by acting on the areas of the brain that control hunger, promoting weight loss by:
- reducing food intake
- making you feel fuller for longer
- delaying the time it takes food to pass through your stomach
Mounjaro’s ability to regulate your appetite and blood glucose levels makes it an effective weight loss medication because it can:
- make it easier for you to reduce your calorie intake
- reduce food cravings
- limit blood sugar spikes
How long does Mounjaro take to work?
Mounjaro starts to work within a few hours of your first injection, however, it can take a few weeks for you to start fully noticing its effects. Your Mounjaro dosage will be increased slowly over a number of weeks to reduce the risk of side effects.
If you have not lost at least 5% of your starting body weight after 6 months, your doctor will probably advise you to stop using Mounjaro, as it’s unlikely to be an effective weight loss medication for you.
How much weight will I lose on Mounjaro?
Clinical trials have shown that Mounjaro helps people lose up to 22.5%* of their initial body weight in 72 weeks when they use the highest maintenance dose of 15mg per week.
Mounjaro works best for weight loss when it is taken alongside healthy lifestyle changes such as a healthy, balanced diet and regular exercise.
Dosing and Administration
- Starting and titration: Mounjaro is typically started at a low weekly dose (commonly 2.5 mg once weekly for 4 weeks) and then increased in 2.5 mg increments every 4 weeks as tolerated up to a maximum of 15 mg once weekly for glycaemic control; follow your prescriber’s exact schedule.
- Formulations: available as prefilled single‑dose pens in multiple strengths to support stepwise titration.
- Injection sites: subcutaneous injection into the abdomen, thigh, or upper arm; rotate sites and inject on the same day each week.
- Missed dose: follow prescriber guidance—do not double doses to make up for a missed injection.
Mounjaro is available in 6 different doses:
- 2.5mg
- 5mg
- 7.5mg
- 10mg
- 12.5mg
- 15mg
How to use Mounjaro injection pen
To inject Mounjaro safely, you should always follow the package leaflet instructions and guidance from your doctor to ensure you have a correct injection technique.
Prepare your pen:
- Wash your hands thoroughly with soap and warm water.
- Remove the pen cap and check the medication has not expired, is not damaged, and the solution is clear to slightly yellow in appearance.
- Wipe the red inner seal with a swab.
- Select a new pen needle and attach it to the pen.
- Remove the outer needle shield and place it to one side.
- Pull off the inner needle shield and throw it away.
- Slowly turn the dose knob until you hear 2 clicks and the extended line is shown in the dose window.
- Hold your pen with the needle pointing up and tap the cartridge holder gently to collect any air bubbles at the top.
- Prime the pen by releasing air bubbles.
If, after you have primed your pen, you do not see any medicine, you should repeat steps 7 to 9 no more than 2 more times.If you still don’t see any medicine, you should contact your local pharmacy or doctor for advice.
Mounjaro injection sites
Mounjaro can be injected into your:
- thigh
- abdomen
- upper arm
Benefits and Clinical Considerations
- Glycaemic control: Mounjaro significantly lowers HbA1c when added to diet and exercise in adults with type 2 diabetes.
- Weight loss: patients commonly experience clinically meaningful weight reduction, which contributes to improved metabolic outcomes.
- Convenience: once‑weekly dosing can improve adherence compared with daily therapies.
Safety, Side Effects, and Contraindications
- Boxed warning: rodent studies showed thyroid C‑cell tumors; Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Common adverse effects: gastrointestinal symptoms such as nausea, vomiting, diarrhea, and decreased appetite are the most frequent and often occur during dose escalation.
- Serious risks: reported risks include pancreatitis, acute kidney injury, and increased hypoglycemia risk when combined with insulin or insulin secretagogues; monitor patients closely and adjust concomitant medications as needed.
- Allergic reactions and injection‑site reactions have also been reported; seek immediate care for signs of severe hypersensitivity.
Practical Patient Tips
- Follow the titration schedule to reduce GI side effects and improve tolerability.
- Discuss medication adjustments with your clinician if you use insulin or sulfonylureas to lower hypoglycemia risk.
- Report severe abdominal pain, persistent nausea/vomiting, or sudden changes in kidney function promptly.
- Inform your prescriber about personal or family thyroid cancer history before starting Mounjaro.
FAQ
- Is Mounjaro once weekly? Yes; it is administered once weekly with stepwise dose escalation.
- Can Mounjaro cause weight loss? Many patients experience clinically meaningful weight reduction while on tirzepatide.
- Who should not take Mounjaro? Patients with personal or family history of medullary thyroid carcinoma or MEN 2 should not use Mounjaro due to the boxed warning.
